Ocular surface epitheliotrophic receptors

This target profile refers to the collective group of endogenous receptors located on the ocular surface—specifically the corneal and conjunctival epithelia—that are activated by the complex biochemical components of natural serum. These receptors include the Epidermal Growth Factor Receptor (EGFR), Transforming Growth Factor-beta Receptors (TGFBR), Fibronectin-binding integrins, and Vitamin A receptors (RAR/RXR). When activated by serum-derived ligands such as EGF, TGF-β, fibronectin, and retinol, these receptors initiate signaling cascades (e.g., MAPK and PI3K/Akt pathways) that drive epithelial cell proliferation, migration, and adhesion. This multi-receptor activation is critical for maintaining the integrity of the ocular surface and promoting the healing of corneal wounds. In therapeutic contexts, this mechanism is harnessed through the use of autologous or allogeneic serum eye drops, which serve as a surrogate for natural tears in patients with severe ocular surface disease. By providing a synergistic cocktail of epitheliotrophic factors, these treatments address complex pathologies like neurotrophic keratopathy and persistent epithelial defects that do not respond to conventional lubricants.

Other names

Multiple endogenous ocular surface receptors via natural serum componentsSerum-activated ocular receptorsAutologous serum eye drop targetsCorneal growth factor receptors

Activation of a broad array of endogenous receptors (including EGFR, TGFBR, FGFR, and integrins) by serum-derived growth factors, vitamins, and adhesion proteins to promote corneal epithelial repair and homeostasis.